Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. SLGL
stocks logo

SLGL

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
AI Stock Picker
AI Stock Picker
Wall Street analysts forecast SLGL stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for SLGL is 50.00 USD with a low forecast of 50.00 USD and a high forecast of 50.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Analyst Rating
Wall Street analysts forecast SLGL stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for SLGL is 50.00 USD with a low forecast of 50.00 USD and a high forecast of 50.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 40.700
sliders
Low
50.00
Averages
50.00
High
50.00
Current: 40.700
sliders
Low
50.00
Averages
50.00
High
50.00
H.C. Wainwright
Raghuram Selvaraju
upgrade
$6 -> $50
2025-10-27
Reason
H.C. Wainwright
Raghuram Selvaraju
Price Target
$6 -> $50
2025-10-27
upgrade
Reason
H.C. Wainwright analyst Raghuram Selvaraju raised the firm's price target on Sol-Gel Technologies to $50 from $6 and keeps a Buy rating on the shares to reflect the 1-for-10 reverse stock split.
See All Ratings

Valuation Metrics

The current forward P/E ratio for Sol Gel Technologies Ltd (SLGL.O) is -8.37, compared to its 5-year average forward P/E of -6.87. For a more detailed relative valuation and DCF analysis to assess Sol Gel Technologies Ltd 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-6.87
Current PE
-8.37
Overvalued PE
50.92
Undervalued PE
-64.66

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
-7.12
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
8.63
Undervalued EV/EBITDA
-22.86

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
12.93
Current PS
0.00
Overvalued PS
32.41
Undervalued PS
-6.54
Financial AI Agent
Financial AI Agent

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %
N/A
ROIC

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Intellectia AI SwingMax
Intellectia AI SwingMax

SLGL News & Events

Events Timeline

(ET)
2025-11-20
07:32:28
Sol-Gel Technologies announces Q3 earnings per share of $2.13 compared to a loss of 13 cents last year.
select
2025-09-04 (ET)
2025-09-04
07:18:03
Sol-Gel Technologies Receives Health Canada Approval for EPSOLAY
select
2025-08-15 (ET)
2025-08-15
07:03:43
Sol-Gel Technologies reports Q2 EPS $4.17 vs 71c last year
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
4.0
10-27Benzinga
Booking Holdings Expected to Surge by 12%? Check Out 10 Leading Analyst Predictions for Monday

  • Analyst Rating Changes: Several Wall Street analysts have adjusted their price targets and ratings for various companies, including DraftKings, Avidity Biosciences, and Glaukos Corp, reflecting a mix of upgrades and downgrades.

  • Notable Price Target Increases: Avidity Biosciences saw its price target raised significantly by Bernstein, while Exagen and Estee Lauder also received upward adjustments from Canaccord Genuity.

  • Upgrades and Downgrades: Glaukos Corp was upgraded by Wells Fargo, while Kura Sushi USA experienced a downgrade from Benchmark, despite both maintaining Buy ratings.

  • Current Stock Prices: The article provides the latest closing prices for the mentioned stocks, indicating market performance and analyst sentiment.

[object Object]
Preview
9.0
09-05NASDAQ.COM
Implications of Health Canada's EPSOLAY Approval for Sol-Gel Technologies' Stock

  • Regulatory Approval: Sol-Gel Technologies Ltd. received Health Canada's approval for EPSOLAY, a topical cream for treating rosacea, marking a significant expansion beyond the U.S. market.

  • Stock Performance and Financial Outlook: Following the approval, SLGL shares surged nearly 20%, and the company anticipates up to $11 million in milestone payments and royalties from EPSOLAY and TWYNEO in Canada, with further international launches expected to enhance revenue by 2031.

[object Object]
Preview
2.0
08-21NASDAQ.COM
Sol-Gel Stock Soars Over 150% - Will Upcoming Q4 Clinical Data Support Continued Growth?

  • Stock Performance: Sol-Gel Technologies Ltd. (SLGL) reached a 52-week high of $18.66, indicating increased investor confidence, with expectations for continued upward momentum as clinical trial milestones approach.

  • Drug Development: The company has two FDA-approved products and is advancing SGT-610 for Gorlin syndrome and SGT-210 for Darier disease, both targeting rare skin conditions with significant market potential.

  • Clinical Trials: SGT-610 is in phase III trials with results expected in Q4 2026, while SGT-210 is in phase 1b trials with results anticipated in Q4 2025, potentially leading to substantial sales if approved.

  • Financial Position: As of June 30, 2025, Sol-Gel had $24.2 million in cash, sufficient to fund operations until early 2027, and the stock has seen a significant increase of over 150% since May 2025.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Sol Gel Technologies Ltd (SLGL) stock price today?

The current price of SLGL is 40.7 USD — it has increased 2.31 % in the last trading day.

arrow icon

What is Sol Gel Technologies Ltd (SLGL)'s business?

Sol-Gel Technologies Ltd is a clinical-stage dermatology company. The Company is focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The Company’s offers a range of products twins, sirs-t, and vered. The Company is designed its proprietary, silica-based microencapsulation technology platform to enhance the tolerability and stability of topical drugs while maintaining their efficacy. Topical drugs often struggle to balance achieving both high efficacy and high tolerability. Its technology platform entraps active ingredients in an inert, inorganic silica shell, which creates an unnoticeable barrier between the active ingredient and the skin.

arrow icon

What is the price predicton of SLGL Stock?

Wall Street analysts forecast SLGL stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for SLGL is 50.00 USD with a low forecast of 50.00 USD and a high forecast of 50.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Sol Gel Technologies Ltd (SLGL)'s revenue for the last quarter?

Sol Gel Technologies Ltd revenue for the last quarter amounts to 400.00K USD, decreased -92.54 % YoY.

arrow icon

What is Sol Gel Technologies Ltd (SLGL)'s earnings per share (EPS) for the last quarter?

Sol Gel Technologies Ltd. EPS for the last quarter amounts to -2.13 USD, increased 1538.46 % YoY.

arrow icon

What changes have occurred in the market's expectations for Sol Gel Technologies Ltd (SLGL)'s fundamentals?

The market is revising No Change the revenue expectations for Sol-Gel Technologies Ltd. (SLGL) for FY2025, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by 45.57%.
arrow icon

How many employees does Sol Gel Technologies Ltd (SLGL). have?

Sol Gel Technologies Ltd (SLGL) has 34 emplpoyees as of December 05 2025.

arrow icon

What is Sol Gel Technologies Ltd (SLGL) market cap?

Today SLGL has the market capitalization of 110.82M USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free